| Doug Schwartzsmith Psyd, Ltd | |
|
231 Awakea Rd Kailua HI 96734-3448 | |
| (808) 261-3684 | |
| (808) 261-3979 |
| Full Name | Doug Schwartzsmith Psyd, Ltd |
|---|---|
| Speciality | Psychologist |
| Location | 231 Awakea Rd, Kailua, Hawaii |
| Authorized Official Name and Position | Doug Fitch Schwartzsmith (PRESIDENT) |
| Authorized Official Contact | 8082613684 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Doug Schwartzsmith Psyd, Ltd 231 Awakea Rd Kailua HI 96734-3448 Ph: (808) 261-3684 | Doug Schwartzsmith Psyd, Ltd 231 Awakea Rd Kailua HI 96734-3448 Ph: (808) 261-3684 |
| NPI Number | 1265441281 |
|---|---|
| Provider Enumeration Date | 08/07/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 7416224613 |
|---|---|
| Medicare Enrollment ID | O20170518000721 |
News Archive
The Boston Globe: Massachusetts officials are holding public comment sessions on a proposed sale of chain of hospitals in the state, and "scores of local officials, state representatives, community leaders, and employees and retirees of Caritas hospitals in Eastern Massachusetts have paraded to the podium to praise Caritas management and the private equity firm, Cerberus Capital Management, that has pledged to preserve the chain of six hospitals, at least for three years."
Researchers at St. Jude Children's Research Hospital have created a massive database of the changes in gene activity of individual cells in the cerebellum during embryonic development and immediately after birth.
A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265441281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY842 (Hawaii) | Primary |
| Provider Name | Doug F Schwartzsmith |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1326057340 PECOS PAC ID: 3870736051 Enrollment ID: I20170518000938 |
News Archive
The Boston Globe: Massachusetts officials are holding public comment sessions on a proposed sale of chain of hospitals in the state, and "scores of local officials, state representatives, community leaders, and employees and retirees of Caritas hospitals in Eastern Massachusetts have paraded to the podium to praise Caritas management and the private equity firm, Cerberus Capital Management, that has pledged to preserve the chain of six hospitals, at least for three years."
Researchers at St. Jude Children's Research Hospital have created a massive database of the changes in gene activity of individual cells in the cerebellum during embryonic development and immediately after birth.
A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
› Verified 8 days ago
News Archive
The Boston Globe: Massachusetts officials are holding public comment sessions on a proposed sale of chain of hospitals in the state, and "scores of local officials, state representatives, community leaders, and employees and retirees of Caritas hospitals in Eastern Massachusetts have paraded to the podium to praise Caritas management and the private equity firm, Cerberus Capital Management, that has pledged to preserve the chain of six hospitals, at least for three years."
Researchers at St. Jude Children's Research Hospital have created a massive database of the changes in gene activity of individual cells in the cerebellum during embryonic development and immediately after birth.
A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
› Verified 8 days ago
The Journey Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 328 Uluniu St Ste 202, Kailua, HI 96734 Phone: 808-277-2273 Fax: 866-278-4162 | |
Aloha Behavioral Practice Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 539 Kalolina St, Kailua, HI 96734 Phone: 334-447-8965 | |
Amazing Behaving Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 417 Kaimake Loop, Kailua, HI 96734 Phone: 808-295-2453 | |
Gordan J Trockman Md Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 970 N Kalaheo Avenue, Suite A102, Kailua, HI 96734 Phone: 808-254-6484 Fax: 808-254-6427 | |
Carmenne Chiasson, Phd Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 389 Kaimake Loop, Kailua, HI 96734 Phone: 808-589-9158 Fax: 808-550-0992 | |
Pacific Counseling Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 780 Kaipii St, Kailua, HI 96734 Phone: 808-291-8582 | |
Pukoa Kulia, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 Hekili St # A1606, Kailua, HI 96734 Phone: 401-203-4971 |